Investigational Site Number 840018

New York, New York 10032

0 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Neoplasm, Type 2 Diabetes Mellitus

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications — Completed